Different clinical models of CD34 + cells mobilization in patients with cardiovascular disease Elisa CangianoCaterina CavazzaRoberto Ferrari OriginalPaper 01 January 2011 Pages: 1 - 8
The many faces of the contact pathway and their role in thrombosis Rebecca S. WoodruffBruce SullengerRichard C. Becker OriginalPaper 15 March 2011 Pages: 9 - 20
Dose Selection for a Direct and Selective Factor IXa Inhibitor and its Complementary Reversal Agent: Translating Pharmacokinetic and Pharmacodynamic Properties of the REG1 System to Clinical Trial Design T. J. PovsicM. G. CohenR. C. Becker OriginalPaper 19 April 2011 Pages: 21 - 31
Evaluation of venous thromboembolism risk following hospitalization Sheryl J. HernerDwight C. PaulsonThomas G. Vondracek OriginalPaper 31 December 2010 Pages: 32 - 39
Pulmonary embolism prophylaxis with inferior vena cava filters in trauma patients: a systematic review using the meta-analysis of observational studies in epidemiology (MOOSE) guidelines Anita RajasekharRichard LottenbergDarwin Ang OriginalPaper 11 January 2011 Pages: 40 - 46
Toward development of a point-of-care assay of enoxaparin anticoagulant activity in whole blood Mario A. Inchiosa Jr.Suryanarayana PothulaIris Navarro OriginalPaper 07 January 2011 Pages: 47 - 53
Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel Fabio MangiacapraAaron J. PeaceEmanuele Barbato OriginalPaper 11 January 2011 Pages: 54 - 58
Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy Mehmet AgirbasliMesut ErenDouglas E. Vaughan OriginalPaper 11 February 2011 Pages: 59 - 63
Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel Michalis HamilosOlivier MullerEmanuele Barbato OriginalPaper 03 February 2011 Pages: 64 - 71
Hypothermia in cardiogenic shock reduces systemic t-PA release Jesper van der PalsMichael I. GötbergDavid Erlinge OriginalPaper 29 December 2010 Pages: 72 - 81
Hyper-homocysteinemia: a novel risk factor or a powerful marker for cardiovascular diseases? Pathogenetic and therapeutical uncertainties Federico Cacciapuoti OriginalPaper 14 January 2011 Pages: 82 - 88
Real-world practices to prevent venous thromboembolism with pharmacological prophylaxis in US orthopedic surgery patients: an analysis of an integrated healthcare database G. J. MerliE. MalangoneL. Stern OriginalPaper 09 February 2011 Pages: 89 - 95
Early stroke-related deep venous thrombosis: risk factors and influence on outcome Jan BembenekMichal KarlinskiAnna Czlonkowska OriginalPaper Open access 26 February 2011 Pages: 96 - 102
The triglyceride:high-density lipoprotein-cholesterol ratio and steno-occlusive disease in the intracranial arteries Kyusik KangKwangsub LeeSung-Hoon Chung OriginalPaper 28 January 2011 Pages: 103 - 109
The association of L-selectin polymorphisms with L-selectin serum levels and risk of ischemic stroke Ye-Sheng WeiYan LanLe-Gen Nong OriginalPaper 05 April 2011 Pages: 110 - 115
Prevalence of factor V Leiden in south Tunisian blood donors Lobna MaalejBasma HadjkacemJalel Gargouri OriginalPaper 23 March 2011 Pages: 116 - 119
Recurrent myocardial infarction associated with gefitinib therapy Donald R. Lynch Jr.Thomas S. KicklerJeffrey J. Rade OriginalPaper 25 December 2010 Pages: 120 - 124
Early-onset obesity and the unwanted promise of thrombosis Richard C. Becker EditorialNotes 25 February 2011 Pages: 125 - 128
